Panbela Therapeutics, Inc.

Panbela Therapeutics, Inc.verified

PBLA

Price:

$0.32

Market Cap:

$1.55M

Panbela Therapeutics, Inc., a clinical-stage biopharmaceutical company, together with its subsidiaries, focuses on developing disruptive therapeutics for the treatment of patients with cancer. The company focuses on diseases of the pancreas, including pancreatitis and pancreatic cancer, as well as neoadjuvant pancreatic cancer, colorectal cancer, ovarian cancer, and other agents in other cancer indications. Its lead product candidate is SBP-101, which is in Phase Ia/Ib clinical trial for the treatment of patients with metastatic pancreatic ductal adenocarcinoma. The company was formerly known as Sun BioPharma, Inc. and changed its name to Panbela Therapeutics, Inc. in December 2020. Panbela ...[Read more]

Industry

Biotechnology

IPO Date

2017-01-03

Stock Exchange

NASDAQ

Ticker

PBLA

The Enterprise Value as of December 2024 (TTM) for Panbela Therapeutics, Inc. (PBLA) is 7.81M

According to Panbela Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 7.81M. This represents a change of -99.28% compared to the average of 1.09B of the last 4 quarters.

Panbela Therapeutics, Inc. (PBLA) Historical Enterprise Value (quarterly & annually)

How has PBLA Enterprise Value performed in the past?

The mean historical Enterprise Value of Panbela Therapeutics, Inc. over the last ten years is 110.89M. The current 7.81M Enterprise Value has changed 603.87% with respect to the historical average. Over the past ten years (40 quarters), PBLA's Enterprise Value was at its highest in in the December 2023 quarter at 4.34B. The Enterprise Value was at its lowest in in the June 2023 quarter at -324410.00.

Quarterly (TTM)
Annual

Average

110.89M

Median

7.73M

Minimum

441.80K

Maximum

714.71M

Panbela Therapeutics, Inc. (PBLA) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Panbela Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 15.30%

Maximum Annual Enterprise Value = 714.71M

Minimum Annual Increase = -93.36%

Minimum Annual Enterprise Value = 441.80K

Quarterly (TTM)
Annual
YearEnterprise ValueChange
20232.62M-62.92%
20227.06M-15.84%
20218.39M-54.67%
202018.51M-14.35%
201921.61M-93.36%
2018325.29M-54.49%
2017714.71M15.30%
20164.64M-18.32%
20155.68M1.19%
2014441.80K-19.57%

Panbela Therapeutics, Inc. (PBLA) Average Enterprise Value

How has PBLA Enterprise Value performed in the past?

The current Enterprise Value of Panbela Therapeutics, Inc. (PBLA) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

6.02M

5-year avg

11.64M

10-year avg

110.89M

Panbela Therapeutics, Inc. (PBLA) Enterprise Value vs. Peers

How is PBLA’s Enterprise Value compared to its peers?

Panbela Therapeutics, Inc.’s Enterprise Value is greater than ZyVersa Therapeutics, Inc. (2.41M), greater than Sonnet BioTherapeutics Holdings, Inc. (-1921489.00), greater than Revelation Biosciences, Inc. (-3873915.00), greater than Navidea Biopharmaceuticals, Inc. (-2595051.00), greater than Altamira Therapeutics Ltd. (1.02M), greater than Palisade Bio, Inc. (-4319316.00), greater than Virax Biolabs Group Limited (3.63M), greater than Quoin Pharmaceuticals, Ltd. (544.30K), less than Unicycive Therapeutics, Inc. (45.27M), less than Cardio Diagnostics Holdings, Inc. (47.27M), greater than PaxMedica, Inc. Common Stock (328.27K), less than Blue Water Vaccines, Inc. (13.53M), greater than Hillstream BioPharma, Inc. (1.48M), greater than Kiora Pharmaceuticals, Inc. (4.97M),

Build a custom stock screener for Panbela Therapeutics, Inc. (PBLA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Panbela Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Panbela Therapeutics, Inc. (PBLA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Panbela Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Panbela Therapeutics, Inc.'s Enterprise Value?

What is the highest Enterprise Value for Panbela Therapeutics, Inc. (PBLA)?

What is the 3-year average Enterprise Value for Panbela Therapeutics, Inc. (PBLA)?

What is the 5-year average Enterprise Value for Panbela Therapeutics, Inc. (PBLA)?

How does the current Enterprise Value for Panbela Therapeutics, Inc. (PBLA) compare to its historical average?